Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis

Acta Haematol (2019) 141 (3): 164–175.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?

Clara Aparicio-Pérez
Esther Prados de la Torre
Joaquin Sanchez-Garcia
Carmen Martín-Calvo
Carmen Martínez-Losada
Javier Casaño-Sanchez
Juana Serrano-López
Josefina Serrano

Cancers (2023) 15 (5): 1425.

Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant

Scott R. Solomon
Melhem Solh
Lawrence E. Morris
H. Kent Holland
Lizamarie Bachier-Rodriguez
Xu Zhang
Caitlin Guzowski
Katelin C Jackson
Stacey Brown
Asad Bashey

Blood Advances (2023) 7 (18): 5215.

HLA-mismatched micro-transplantation as post-remission treatment compared to autologous hematopoietic stem cell transplantation or consolidation with single agent cytarabine for favorable-or intermediate-risk acute myeloid leukemia

Shandong Tao
Dan Zhou
Lixiao Song
Yuan Deng
Yue Chen
Banghe Ding
Zhengmei He
Chunling Wang
Liang Yu

Hematology (2023) 28 (1)

Controversial Flow Cytometry Monitoring of a Relapse Case of Pediatric T Cell Acute Lymphoblastic Leukemia: A Case Report

Delia Codruţa Popa
Andreea Şerbănică
Radu Obrisca
Ionut Şerbănică
Letiţia Radu
Cristina Jercan
Andra Marcu
Ana Bica
Minodora Asan
Mădălina Petran
Mihaela Dragomir
Cerasela Jardan
Valeria Ţică
Anca Gheorghe
Irina Stoian
Daniel Coriu
Anca Coliţă
Andrei Coliţă

Frontiers in Medicine (2022) 9

Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: An Overview of Systematic Reviews

Peijie He
Juan Liang
Wanjun Zhang
Shengyun Lin
Hanting Wu
Qiushuang Li
Xiujuan Xu
Conghua Ji
Pier Paolo Piccaluga

International Journal of Clinical Practice (2022) 2022: 1.

Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes

Sijian Yu
Zhiping Fan
Liping Ma
Yu Wang
Fen Huang
Qing Zhang
Jiafu Huang
Shunqing Wang
Na Xu
Li Xuan
Mujun Xiong
Lijie Han
Zhiqiang Sun
Hongyu Zhang
Hui Liu
Guopan Yu
Pengcheng Shi
Jun Xu
Meiqing Wu
Ziwen Guo
Yiying Xiong
Chongyang Duan
Jing Sun
Qifa Liu
Yu Zhang

JAMA Network Open (2021) 4 (7): e2115991.

Comparison of Post-Remission Strategies in Acute Myeloid Leukemia: Autologous Hematopoietic Stem Cell Transplantation versus Consolidation Chemotherapy

Zeynep Yegin
Asena Dikyar
Lale Kaynar
Ferda Can
Zübeyde Özkurt
Münci Yağcı

Hematology Reports (2020) 12 (3): 8380.

Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission

Roni Shouval
Myriam Labopin
David Bomze
Gabriela M. Baerlocher
Saveria Capria
Didier Blaise
Mathias Hänel
Edouard Forcade
Anne Huynh
Riccardo Saccardi
Giuseppe Milone
Tsila Zuckerman
Péter Reményi
Jurjen Versluis
Jordi Esteve
Norbert Claude Gorin
Mohamad Mohty
Arnon Nagler

Bone Marrow Transplantation (2020) 55 (12): 2244.

Haploidentical Hematopoietic Stem Cell Transplantation Versus Umbilical Cord Blood Transplantation in Hematologic Malignancies: A Systematic Review and Meta-Analysis

Ran Wu
Liyuan Ma

Cell Transplantation (2020) 29: 096368972096477.